Secukinumab in a patient with sarcoidosis
dc.authorid | Şenol Kobak / 0000-0001-8270-640X | en_US |
dc.authorid | Adil Can Güngen / 0000-0002-2676-723X | en_US |
dc.authorid | Yıldıray Tutpınar / 0000-0001-9445-6604 | |
dc.authorscopusid | Şenol Kobak / 12782228700 | |
dc.authorscopusid | Adil Can Güngen / 56682130600 | |
dc.authorscopusid | Belma Doğan Güngen / 56841681700 | |
dc.authorscopusid | Yıldıray Tutpınar / 25923172200 | |
dc.authorscopusid | Mürüvet Güler / 57218710925 | |
dc.authorwosid | Şenol Kobak / AAO-2482-2020 | |
dc.authorwosid | Adil Can Güngen / CSH-3078-2022 | |
dc.authorwosid | Belma Doğan Güngen / CST-6053-2022 | |
dc.authorwosid | Yıldıray Tutpınar / ECZ-3455-2022 | |
dc.authorwosid | Mürüvet Güler / CRM-6695-2022 | |
dc.contributor.author | Kobak, Şenol | |
dc.contributor.author | Güngen, Adil Can | |
dc.contributor.author | Doğan Güngen, Belma | |
dc.contributor.author | Tutpınar, Yıldıray | |
dc.contributor.author | Güler, Mehtap | |
dc.date.accessioned | 2020-09-10T13:27:31Z | |
dc.date.available | 2020-09-10T13:27:31Z | |
dc.date.issued | 2020 | |
dc.department | İstinye Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü | en_US |
dc.description.abstract | Sarcoidosis is a systemic granulomatous disease, characterized by non-caseating granuloma formation. It usually involves the lungs, but may also affect the eyes, heart, skin, and musculoskeletal system. The pathogenesis is not well known, but it is generally accepted as Th1 disease. The role of Th17-induced cytokines in the development of sarcoid granuloma has been reported. | en_US |
dc.identifier.citation | Kobak, S., Gungen, A. C., Gungen, B. D., Tutpinar, Y., & Guler, M. (2020). Secukinumab in a patient with sarcoidosis. Scandinavian Journal of Rheumatology, 1-2. | en_US |
dc.identifier.doi | 10.1080/03009742.2020.1784460 | en_US |
dc.identifier.issn | 0300-9742 | en_US |
dc.identifier.pmid | 32870066 | en_US |
dc.identifier.scopus | 2-s2.0-85090166204 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.uri | https://doi.org/10.1080/03009742.2020.1784460 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12713/1010 | |
dc.identifier.wos | WOS:000565011100001 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.institutionauthor | Kobak, Şenol | |
dc.institutionauthor | Güngen, Adil Can | |
dc.institutionauthor | Doğan Güngen, Belma | |
dc.institutionauthor | Tutpınar, Yıldıray | |
dc.institutionauthor | Güler, Mehtap | |
dc.language.iso | en | en_US |
dc.publisher | Taylor and Francis Ltd | en_US |
dc.relation.ispartof | Scandinavian Journal of Rheumatology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.title | Secukinumab in a patient with sarcoidosis | en_US |
dc.type | Letter | en_US |